Last reviewed · How we verify
Insulin infusion with basal insulin and bolus — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Insulin infusion with basal insulin and bolus (Insulin infusion with basal insulin and bolus) — Tanta University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Insulin infusion with basal insulin and bolus TARGET | Insulin infusion with basal insulin and bolus | Tanta University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Insulin infusion with basal insulin and bolus CI watch — RSS
- Insulin infusion with basal insulin and bolus CI watch — Atom
- Insulin infusion with basal insulin and bolus CI watch — JSON
- Insulin infusion with basal insulin and bolus alone — RSS
Cite this brief
Drug Landscape (2026). Insulin infusion with basal insulin and bolus — Competitive Intelligence Brief. https://druglandscape.com/ci/insulin-infusion-with-basal-insulin-and-bolus. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab